| Old Articles: <Older 161-170 Newer> |
 |
Bio-IT World November 12, 2002 Paula Campbell Evans |
Patently More Difficult The PTO has targeted gene patents with new application guidelines. Here's what they mean and how biotech companies can satisfy them.  |
Bio-IT World November 12, 2002 Beth E. Arnold |
Navigating Gene Patent Minefields As the number of gene-related patents soars, so do the chances of patent infringement. Here are tips to avoid a costly misstep in this legal minefield.  |
Bio-IT World November 12, 2002 Sue Mayer |
Are Gene Patents in the Public Interest? Two recent studies from Britain argue against the unbridled patenting of genes and raise tough ethical questions.  |
Salon.com October 28, 2002 Katharine Mieszkowski |
Data-mining life on earth Every blade of grass, every fish and fowl, slug and snail, has a place on the Web.  |
Wired November 2002 David Ewing Duncan |
DNA as Destiny DNA is the book of life. It's also the book of death. In the future we'll all be read cover to cover. Here's what it's like to take the world's first top-to-bottom gene scan.  |
CIO October 15, 2002 Stephanie Overby |
They Want a New Drug In the race to develop new pharmaceuticals more quickly, companies are introducing new IT tools. But the tools can't do it alone. CIOs need to change the way people do their work.  |
Science News October 12, 2002 Ivars Peterson |
Catching Flies Experiments to determine how the archerfish understands the trajectory of its prey.  |
Science News October 12, 2002 Janet Raloff |
FDA Launches Acrylamide Investigations Research efforts spawned by the discovery that acrylamide, a carcinogen, is formed in some foods like french fries and potato chips when they are cooked.  |
Science News October 12, 2002 |
A Prized Worm This year's Nobel Prize in physiology or medicine went to researchers who pioneered the use of the tiny worm Caenorhabditis elegans as an animal model for exploring basic processes involved in the development and behavior of multicellular organisms.  |
Bio-IT World October 9, 2002 Malorye Branca |
The Path to Personalized Medicine The tactics have changed, sometimes dramatically, but hints of the promise of pharmacogenomics are finally starting to trickle in from studies of asthma, cancer, and drug response.  |
| <Older 161-170 Newer> Return to current articles. |